ArticleNPJ precision oncology2026

Novel activating SNRNP70-ALK fusion in congenital infant-type hemispheric glioma displays clinical response to lorlatinib: a case-report.

Cecilia Arthur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.